* Amphastar Pharmaceuticals Inc AMPH.OQ reported quarterly
adjusted earnings of 94 cents per share for the quarter ended
in June, higher than the same quarter last year, when the
company reported EPS of 65 cents. The mean expectation of
six analysts for the quarter was for earnings of 77 cents per
share. Wall Street expected results to range from 71 cents to 89
cents per share.
* Revenue rose 25.2% to $182.39 million from a year ago;
analysts
expected $170.94 million.
* Amphastar Pharmaceuticals Inc's reported EPS for the
quarter was
73 cents.
* The company reported quarterly net income of $37.95
million.
* Amphastar Pharmaceuticals Inc shares had fallen by 1.5%
this
quarter and lost 36.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.
* In the last 30 days, two analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $66.00
This summary was machine generated from LSEG data August 7 at
11:17 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.77 0.94 Beat
Mar. 31 2024 0.96 1.04 Beat
Dec. 31 2023 0.93 0.88 Missed
Sep. 30 2023 0.69 1.15 Beat